share_log

HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $3

HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $3

HC Wainwright & Co.维持对Mainz Biomed的买入,将目标股价下调至3美元
Benzinga ·  03/06 12:03

HC Wainwright & Co. analyst Yi Chen maintains Mainz Biomed (NASDAQ:MYNZ) with a Buy and lowers the price target from $5 to $3.

HC Wainwright & Co. 分析师陈毅维持美因兹生物医学(纳斯达克股票代码:MYNZ)的买入并将目标股价从5美元下调至3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发